Rationale: Wound healing after myocardial infarction involves a highly regulated inflammatory response that is initiated by the appearance of neutrophils to clear out dead cells and matrix debris. Neutrophil infiltration is controlled by multiple secreted factors, including the master regulator transforming growth factor β (TGFβ). Broad inhibition of TGFβ early postinfarction has worsened post-myocardial infarction remodeling; however, this signaling displays potent cell specificity, and targeted suppression particularly in the myocyte could be beneficial.
C oronary artery disease is the leading cause of death worldwide, and myocardial infarction (MI) is among its most severe manifestations. 1 In the early post-MI period, mortality is due to arrhythmia, cardiogenic shock, and myocardial rupture, whereas ischemic heart failure with molecular and chamber remodeling impacts long-term prognosis. Early aggressive cardiac care including reperfusion therapy has improved outcomes. However, many infarcts remain nonreperfused, 2 and the molecular and cellular events initiated within hours to days often dictate the ultimate consequences of the injury. This continues to drive the efforts to better understand early signaling events that control myocardial damage and repair.
Irreversible injury to cardiomyocytes develops shortly after the onset of ischemia and leads to cell death. Within hours, a rapidly induced, highly regulated inflammatory response consisting largely of neutrophils and monocyte/macrophages is initiated in the myocardium to remove dead cells and matrix debris. [3] [4] [5] These first responder cells also secrete enzymes, free radicals, and cytokines that can induce matrix destabilization and infarct expansion. 4, 6 In humans, neutrophilia is associated with adverse chamber remodeling and propensity to cardiac rupture after infarction. [7] [8] [9] The acute inflammatory response is followed by proliferation of vascular cells and matrix-depositing fibroblasts, formation of granulation tissue, and replacement of this tissue by a collagen-rich scar with high tensile strength. 5 This temporal sequence must be finely orchestrated to prevent excessive early ventricular remodeling.
Transforming growth factor β (TGFβ) is a master regulator of the inflammatory, proliferative, and fibrotic components of infarct healing, 10 placing it in a strategic position to coordinate this temporal sequence. The expression of all 3 TGFβ isoforms is upregulated after ischemia. TGFβ ligand binds to TGFβ receptor 2 (TGFβR2) that in turn recruits and phosphorylates TGFβ receptor 1 (TGFβR1) to initiate SMAD-dependent transcriptional regulation by the classical pathway. TGFβR2 may also couple to alternative cascades such as members of mitogen-activated protein kinase pathways. 11, 12 Direct administration of TGFβ during the inflammatory phase reduces myocardial injury associated with the attenuation of proinflammatory cytokines such as tumor necrosis factor α (TNFα). 13 Conversely, early inhibition of TGFβ increases post-MI mortality, exacerbates left ventricular dilation, and enhances cytokine synthesis. 14, 15 TGFβ induces chemotaxis and activation of circulating monocytes and polymorphonuclear cells, [16] [17] [18] but has a predominantly suppressive effect on mature macrophages. 16, 19, 20 TGFβ is also a potent inducer of myofibroblast formation and stimulates synthesis of extracellular matrix proteins. 10 In addition to this pleomorphic regulation, TGFβ signaling varies depending on the cell type and the receptor (TGFβR1 versus TGFβR2) being modulated, impacting its net role in the heart under pathological stress.
In this study, we tested the hypothesis that myocyte TGFβ impacts cardiac stress signaling after MI in a manner that differs from that observed with global TGFβ suppression. Surviving myocytes in the peri-infarct zone adjoining the necrotic core are strategically positioned to signal to inflammatory, vascular, and other interstitial cells that migrate into the region. Using cell-selective gene knockdown strategies, we show that neutrophilia and myocardial neutrophil migration are suppressed and a constellation of protective cardiokines activated by blocking myocyte TGFβ signaling, preventing early mortality due to infarct rupture.
Methods
An extended Methods section is available in the Online Data Supplement.
Mouse Model of Myocyte-Targeted TGFβR Knockdown
Cardiomyocyte-targeted TGFβ receptor-knockout mice were generated as described. 11 Briefly (TGFβR2  cKD ) . To induce recombination, tamoxifen citrate (Sigma) was administered in soft diet (Bioserve) at 80 mg/ kg per day for 10 days. Experiments were conducted 2 to 4 weeks after tamoxifen treatment when echocardiography confirmed normal baseline function. C57Bl/6J mice (Jackson Laboratories) were used in antibody studies. TGFβ neutralizing antibody (clone 1D11) and control Ab (clone 13C4) were obtained from Genzyme. Ab treatment was initiated at the time of left anterior descending artery ligation by intraperitoneal injection (10 mg/kg body weight, 3 times per week).
Infarction Model
Mice were anesthetized (etomidate 15 mg/kg intraperitoneally, isoflurane 2% to 4% by ventilator, buprenorphine 0.1 mg/kg subcutaneously q6-8h), intubated and ventilated, left anterior descending artery accessed by lateral thoracotomy and pericardectomy, and visualized with a stereomicroscope. Coronary ligation was performed using a 7-0 suture placed caudal to the left atrial appendage. Successful ligation was confirmed by blanching of the myocardium and by ECG monitoring. The wound was closed in layers using 6-0 suture. Mice were closely monitored after surgery and analgesia provided as needed (buprenorphine). The protocol was approved by the Johns Hopkins Medical Institutions Animal Care and Use Committee.
Isolated Ventricular Cardiomyocyte Culture Studies
Neonatal rat cardiac ventricular myocytes were isolated from 1-to 3-day-old Sprague-Dawley rats as described 21 and maintained in 10% fetal bovine serum containing culture media after isolation. For RNA interference, ON-TARGETplus SMARTpool reagent against rat TGFβR1 was purchased from Dharmacon. ON-TARGETplus nontargeting pool was used as control. Twenty-four hours after plating, cells were transfected with 25 nmol/L siRNA using DharmaFECT 1 reagent following the manufacturer's protocol in OptiMEM media (Gibco). Twenty-four hours before cytokine stimulation, cells were serum-starved. TNFα (50 ng/mL), interleukin (IL)-1β (10 ng/ mL; both R&D Systems), or TGFβ 1 (5 ng/mL; Sigma) were used for cytokine stimulation. For hypoxia studies, cells were exposed to a nitrogen atmosphere containing 5% CO 2 and 1% O 2 in modular incubator chambers (Billups-Rothenberg). PC3 cells transfected with hypoxia-responsive elements driving the expression of GFP 22 and transcript expression of Slc2a1 (GLUT1) served to confirm effective hypoxia. RNA was harvested 24 hours after cytokine stimulation or exposure to hypoxia.
Statistical Analyses
Data are presented as mean±SEM. Group comparisons were performed by 1-or 2-way ANOVA, nonpaired 2-tailed Student t test, Kruskal-Wallis ANOVA, or Mann-Whitney U test as appropriate. Bonferroni correction was used unless indicated otherwise. Survival was compared using log-rank test. P values ≤0.05 were considered significant. Sample sizes and individual statistical results are provided in figures.
Results

Myocyte TGFβ Inhibition Prevents Death Due to Wall Rupture After Myocardial Infarction
We initially studied mice with both cardiomyocyte selective TGFβR1 and TGFβR2 knockdown. After infarction, littermate controls exhibited ≈40% mortality that occurred generally in the first 10 days. By contrast, both TGFβR2 cKD and TGFβR1 cKD mice were protected (1 death in 17 mice; P<0.05; Figure 1A ). When control mice were administered a pan-cell targeting TGFβ-neutralizing antibody, all died by day 5, whereas mice receiving control antibody displayed the anticipated 40% mortality ( Figure 1B (terminal) heart and lung weight, remote fibrosis, and fetal gene expression (Nppa, Nppb, and Myh7) were also similar (Online Figure IIA-IID) . Given the similar phenotypes for myocyte TGFβR1 and TGFβR2 deletion models, we focused our subsequent analyses to TGFβR1 cKD animals. Mortality disparities began at day 3. At this time, all 3 TGFβ isoforms were equally upregulated in the peri-infarction zone of controls and TGFβR1 cKD mice ( Figure 2A ). Canonical TGFβ signaling reflected by Smad2/3 phosphorylation was activated in the peri-infarct zone ( Figure 2B and 2C), whereas noncanonical signaling indexed by TGFβ-activated kinase 1 or mitogen-activated kinases was not ( Figure 2D and 2E). These noncanonical kinases were not differentially changed in TGFβR1 cKD infarcted hearts, with the exception of C-Jun N-terminal kinase that displayed reduced phosphorylation. Confocal immunofluorescence revealed Smad3 activation in both cardiac myocytes and interstitial cells in infarcted control hearts, but only in interstitial cells in TGFβR1 cKD ( Figure 2F ). Thus, TGFβR1 gene deletion in myocytes did not alter ligand expression or total myocardial Smad2/3 activation, but did suppress canonical TGFβ signaling in these cells.
Myocyte TGFβR1 Deletion Attenuates Matrix Metalloproteinase 9 Activity Without Impacting Collagen Deposition
Acute infarct remodeling and vulnerability to wall thinning and rupture represents a balance between matrix degeneration linked to matrix metalloproteinase (MMP) activation and fibrous tissue formation. 5 At day 3 post-MI, when mortality differences began appearing, fibrosis was not yet present ( Figure 3A ). Collagen gene expression was increased but similar between groups ( Figure 3B ). However, the expression of Mmp9 rose nearly 30-fold post-MI, and this was significantly blunted in TGFβR1 cKD myocardium ( Figure 3C ). The MMP inhibitor TIMP1 was similarly elevated in both groups ( Figure 3F ), thereby lowering the Mmp9/Timp1 ratio ( Figure 3G ). Changes in expression were paralleled by MMP9 gelatinolytic activity ( Figure 3D and 3E). MMP2 expression and activity were unchanged ( Figure 3C-3E ). Given the reports that myocytes can be a source of MMP9, 23, 24 we examined Mmp gene expression and gelatinolytic activity in isolated cells as well. Both Mmp2 and Mmp9 expression rose markedly but similarly in control and TGFβR1 cKD myocytes, and gelatinolytic activity was only modestly altered, indicating that other cell types likely regulated total myocardial MMP activity (Online Figure IIIA-IIIC) . This was confirmed by confocal immunofluorescence showing MMP9 to be largely present in the interstitium (Online Figure IIID) , colocalizing with neutrophils in blood vessels and the perivascular region (Ly6G staining; Figure 3H ).
Myocyte TGFβ Inhibition Markedly Reduces Neutrophil Recruitment to the Heart
Neutrophils are a major source of activated MMPs 25 ; therefore, we examined whether their myocardial recruitment was altered in TGFβR1 cKD hearts. At 24 hours, when neutrophils typically peak in the infarct zone, 3 their amount was dramatically reduced in TGFβR1 cKD hearts versus controls ( Figure 4A and 4B). Gene expression of the neutrophil chemokine receptor CXCR2 declined correspondingly ( Figure 4C ). Because neutrophils and other leukocytes home to the infarct from the peripheral circulation and lymphatic tissues, we tested if myocyte TGFβR1 signaling also impacted this mobilization. Blood obtained at 24 hours after infarction showed neutrophilia in controls but not in TGFβR1 cKD mice ( Figure 4D ). Myocardial macrophages also play a prominent role in infarct remodeling, 23 and although blood monocyte levels declined in TGFβR1 cKD MI mice compared with controls (Online Figure IVD) , myocardial recruitment was similar in both hearts (Online Figure IVA-IVC) . Because neutrophil homing can be triggered by cytokine or chemokine expression, we next examined whether these factors were differentially expressed in TGFβR1 cKD hearts. We found only a modest decline in TNFα, whereas other factors such as IL-1β, IL-6, and neutrophil chemokines CXCL1-3 markedly increased post-MI in both control and TGFβR1 cKD hearts ( Figure 4E) . 
TGFβR1 cKD Hearts Exhibit Enhanced Thrombospondin 4-Coupled Endoplasmic Reticulum Stress Response
The failure to suppress proinflammatory mediators despite reduced neutrophil migration suggested that the activation of alternative anti-inflammatory and cytoprotective pathways may be involved. One candidate was thrombospondin because mice lacking thrombospondin 1 show expanded macrophage and fibroblast activity in the border zone with destabilized infarcts, 26 and mice lacking thrombospondin 2 demonstrate spontaneous left ventricular rupture after angiotensin infusion. 27 Thbs1 expression did rise after MI in controls but also similarly in TGFβR1 cKD hearts; Thbs2 was unaltered. However, thrombospondin 4 (Thbs4) expression rose much more in TGFβR1 cKD mice at both gene ( Figure 5A ) and protein ( Figure 5B ) levels. Thbs4 was recently shown to be cardiac-protective when enhanced in myocytes, by stimulating endoplasmic reticular (ER) stress responses. 28 We found Thbs4 mainly expressed within cardiomyocytes at the border zone ( Figure 5C 
Myocyte TGFβ Inhibition Induces the Expression of Multiple Protective Cardiokines
IL-33 is an alarmin, a factor released after tissue injury, that acts as an endogenous danger signal mediating inflammatory responses. 29 It is a ligand for the ST2 receptor and protective against several forms of heart diseases. [30] [31] [32] In infarcted control hearts, Il33 gene expression rose slightly >2-fold, but increased ≈10-fold in TGFβR1 cKD ( Figure 7A ). This translated to higher protein levels as well ( Figure 7B and 7C) . Gene expression levels of ST2 membrane and soluble receptors were unaltered by TGFβR1 deletion (Online Figure VI) . The cellular source of IL-33 in infarcted hearts appeared to be predominantly perivascular interstitial cells ( Figure 7D ).
The marked rise in IL-33 and Thbs4/ER stress responses suggested that the removal of canonical myocyte TGFβ signaling might impact the synthesis of other protective cardiokines as well. Growth and differentiation factor 15 (GDF-15) is a TGFβ-related cytokine expressed and secreted by cardiac myocytes that rises after MI and is induced by the transcription factor follistatin-like 1 (FSTL1). 33, 34 The deletion of GDF-15 enhances neutrophil recruitment to the infarct and increases myocardial rupture, whereas the administration of recombinant protein achieves the opposite. 35 The net disparity in GDF-15 expression was quantitatively similar to that found A B E C D Figure 4 . Neutrophil recruitment to the injured heart is reduced by TGFβR1 cKD without major changes in proinflammatory cytokine and neutrophil chemokine expression patterns. A to C, Recruitment of neutrophils to the infarcted heart is markedly reduced by myocyte transforming growth factor β (TGFβ) inhibition: immunostaining (A) with quantification (B), confirmed by (C) expression analysis of the neutrophil chemokine receptor Cxcr2; between GDF-15 +/− and wild-type mice, the latter displaying 50% lower mortality due to myocardial rupture. GDF-15 interacts directly with neutrophil β2 integrins to limit their activation and extravascular migration into tissue. As expected, gene expression of both FSTL1 and GDF-15 increased after MI in controls, but both rose significantly more in TGFβR1 cKD hearts ( Figure 7E and 7F) . Effective immunostaining for GDF-15 was precluded by the poor sensitivity of existing antibodies; however, we were able to identify strong FSTL1 immunofluorescence in both infarct myocytes and interstitial cells ( Figure 7G) .
The collective presence of various protective cardiokines was accompanied by a reduction in cell death. Apoptotic cells were identified by immunostaining for cleaved caspase-3 and were almost exclusively located in the border zone region after MI and consisted of both interstitial cells and cardiomyocytes ( Figure 8A ; Online Figure VII) . Cleaved caspase-3 levels were significantly lower in TGFβR1 cKD hearts ( Figure 8B ).
Cytokine-or Hypoxia-Stimulated GDF-15 Regulation Is Inversely Controlled by TGFβ
The integrative complexity of multiple cell types signaling via various cytokines and cardiokines raised the question of whether the changes could be directly attributed to myocyte TGFβR downregulation. To test this, we exposed rat neonatal myocytes to 2 simulated aspects of infarction insult, cytokines (IL-1β and TNFα) or hypoxia. Cytokine stimulation induced GDF-15 gene expression, and the coadministration of TGFβ 1 ligand attenuated this response. This suppressive effect of TGFβ 1 on cytokine-induced GDF-15 expression was lost when TGFβR1 was silenced ( Figure 8C ). In the case of hypoxia, we observed a downregulation of GDF-15 in cultured cardiomyocytes, and this was prevented by TGFβR1 silencing ( Figure 8D ). FSTL1 and Thbs4 gene expression was also examined in these cells, but here, regulation by TGFβ 1 stimulation and TGFβR1 silencing led to effects opposite to those observed in vivo. TNFα and IL-1β cytokine stimulation lowered the expression of both genes, and hypoxia reduced Fstl1 expression, and this was not reversed by TGFβR1 silencing (Online Figure VIII) . Conversely, TGFβ 1 ligand stimulation induced the expression of both Fstl1 and Thbs4. Thus, for these proteins, the net changes in vivo depended on other factors not mimicked by the in vitro model or are the consequence of integrative multicell-type crosstalk.
Discussion
The discovery that early neutrophil activation, myocardial migration, and consequent infarct destabilization and rupture are orchestrated by cardiomyocyte TGFβ signaling is surprising, given that the wound healing process is generally considered the domain of inflammatory and matrix-depositing cells. 5 We found that early neutrophil content in TGFβR1 cKD infarcted hearts was nearly 70% lower than in controls despite similar infarct sizes. This in turn was coupled to reduced MMP9 activity and prevention of wall rupture and death. The anti-inflammatory effect was prominent for neutrophils, because macrophage content and the expression of major proinflammatory cytokines were unaltered. Furthermore, cell-selective TGFβ inhibition was required to observe this benefit, whereas early nonselective TGFβ antagonism was detrimental. The precise pathways involved differed from those invoked by pressure overload, where we found myocyte noncanonical signaling to be dominant and protective. 11 In the post MI setting, classical TGFβ cascades were involved.
Previous studies investigated noncell-specific TGFβ inhibition in the setting of MI either by using neutralizing antibody against TGFβ, 15 competitively inhibiting TGFβ signaling using gene transfer of soluble TGFβR2 to skeletal muscle, 14, 36 or using a small-molecule TGFβR1 inhibitor. 37 All demonstrated detrimental effects when global TGFβ inhibition was initiated at the onset of ischemia. 15 This was attributed to the role of TGFβ in suppressing inflammation via neutrophils, myofibroblast activation, and extracellular matrix generation. Here we show that the cell type being modulated plays a critical role, and that canonical TGFβ signaling in the myocyte contributes to the opposite, that is, neutrophil migration and suppressing cardiokines. Selective inhibition of this pathway is protective.
Shortly after the onset of irreversible ischemic damage, myocytes and other cells export cytokines and chemokines that initiate the immune response. As they die, cells also release internal contents including DNA that are highly proinflammatory (damage-associated molecular patterns) [38] [39] [40] ; this along with the appearance of immune cells that secrete cytokines and chemokines themselves creates feed-forward amplification of inflammation, matrix degradation, and infarct expansion. 5 During this early period, the deposition of new matrix and collagen fibers is yet to occur, and the myocardial wall is particularly vulnerable to systolic stress-induced expansion and rupture. The propensity of myocardial wall rupture has been linked to neutrophil infiltration and the activity of matrix metalloproteinases. 23, 35, 41 Later, inflammation recedes and the heart transitions to form a more stable collagen-rich scar.
How does myocyte TGFβ inhibition regulate this sequence? The expression of major proinflammatory cytokines and neutrophil chemokines was comparable between experimental groups. Furthermore, although the suppression of canonical TGFβ signaling in myocytes may have protected some myocytes from programmed cell death, functional decline post-MI was generally similar, suggesting that the primary mechanism of cardioprotection was different. Another possibility was that replacement fibrosis in the infarct zone and hence tensile strength was enhanced by myocyte TGFβR1 deletion; however, collagen deposition was negligible at this time and collagen gene expression elevated to comparable levels between genotypes. Rather than these mechanisms, we propose that the blockade of myocyte TGFβ canonical signaling resulted in the coordinated activation of a secreted protein cascade that included multiple protective cardiokines.
The notion of a cardiac secretome is not new; well-known examples include natriuretic peptides, angiotensin II, or cytokines such as IL-6, TNFα, and TGFβ. However, recent studies have identified a broader set of cardiokines that play regulatory roles in cardiac remodeling. 42 Intriguingly, we found that many of these, including IL-33, ARMET, FSTL1, and GDF-15, were enhanced in TGFβR1 cKD post-MI heart. IL-33 was among the most enhanced, and although its inflammatory regulation varies with the disease, [43] [44] [45] [46] in the heart it protects against pathological remodeling after infarction, myocyte hypoxia, and pressure overload. [30] [31] [32] 47 Intriguingly, IL-33 was predominantly located in nonmyocyte cells in the border zone. This demonstrates that myocyte TGFβR1-dependent signaling is not confined to the myocyte itself, but that intercellular crosstalk originating from the myocyte can ultimately drive IL-33 expression in nonmyocyte cells. Protection against ischemic injury by IL-33 has also been linked to C-Jun N-terminal kinase inhibition and reduced apoptosis, 32,48 and we observed reduced C-Jun N-terminal kinase phosphorylation in TGFβR1 cKD animals. GDF-15, also known as macrophage inhibitory cytokine 1, is a member of the TGFβ superfamily. 49 It is expressed in infarct myocytes and upregulated in infarcted mouse or human hearts. 35 When overexpressed in myocytes, GDF-15 acts as an antihypertrophic factor coupled to the activation of SMAD2/3. 50 Here, we show this signaling in reverse, in that by selectively blocking SMAD2/3 signaling, GDF-15 expression rises; thus, a negative feedback loop seems present. Kempf et al 35 showed that GDF-15 suppresses neutrophil migration by interfering with β2 integrin activation and consequently with neutrophil adhesion and endothelial transmigration. Mice deficient in GDF-15 have increased cardiac neutrophil recruitment after MI associated with wall rupture, whereas enhancing GDF-15 levels is protective. 35 Thus, the augmentation of GDF-15 would be highly consistent with the antineutrophil effect from myocyte TGFβR1 knockdown. GDF-15 also has reported effects on monocytes and macrophages, 35 although in the present analysis of early infarct remodeling, the dominant influence seems to be on neutrophils. FSTL1 is a potent inducer of GDF-15 promoter activity and gene expression 34 and protective in cardiac pressure overload and ischemia/reperfusion 51, 52 and was prominently expressed in myocytes after infarction and further regulated in TGFβR1 cKD hearts. One potential way to integrate the collection of protective cardiokines is through a Thbs4-coupled ER stress response. One ER stress factor, ARMET (also known as mesencephalic astrocyte-derived neurotrophic factor), that was differentially enhanced in the TGFβR1-knockdown model, is induced by ischemia, and its secretion reduces tissue damage. 53, 54 However, the analysis of gene arrays previously obtained in hearts overexpressing Thbs4 in cardiac myocytes 28 did not identify IL-33, FSTL1, or GDF-15 expression changes. This indicates that the collective changes are unlikely coupled to Thbs4-ER stress alone, but to other TGFβ receptor-mediated transcriptional regulation. The finding that in isolated myocytes, the Thbs4 response to TGFβ stimulation was opposite that seen in vivo further supports the importance of complex cell-cell and/or cell-matrix interactions. This may in part involve the role of Thbs4 as a matrix-myocyte mechanosignaling molecule 55 in addition to its role in ER stress. The difficulty in simulating the in vivo environment in a culture dish makes it hard to dissect out these specific influences. Importantly, however, disruption of myocyte TGFβR signaling is sufficient to profoundly alter these multicellular factors and ultimately impact inflammatory and remodeling responses.
A limitation of this study is that the signaling cascade critically responsible for the effects observed in myocyte TGFβR knockdown remains uncertain. Although GDF-15 did seem to be regulated in a consistent direction in the in vitro myocyte models, other cytokines were not, but these reductionist systems do not mimic the complex in vivo environment of an infarction. Because there are no current small-molecule inhibitors of the molecules identified, more complex, dual conditional genetic deletion models would be needed, and this is presently difficult. The present work required studies in mice to enable genetic modulations, but we recognize that such models may not translate to findings in humans, particularly in regard to inflammation. 56 Lastly, the behavior in reperfused infarcts may differ from that in the permanent left anterior descending artery occlusion model. However, ischemia/reperfusion in mice has its own limitations and is less likely to induce wall thinning and rupture phenotype that we studied. Furthermore, a substantial number of MIs remain nonreperfused. 2 In conclusion, we demonstrate that myocyte TGFβ is a master regulator of acute neutrophil inflammatory response in ischemic hearts and controls the myocardial expression of multiple protective factors, each revealed to confer cytoprotection or diminish neutrophil recruitment. This supports a cohesive regulatory pathway, highlights the importance of cell-specific targeting of the TGFβ pathway, and reveals why noncell-selective therapies may have failed in the past. The identification of TGFβ-coordinated pathway(s) that can centrally regulate these multiple cardiokine mediators may ultimately lead to a potent therapeutic approach to suppress maladaptive remodeling in the heart.
